- Home
- VTR vs DXCM Comparison
VTR vs DXCM Comparison
Compare VTR & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTR
- DXCM
- Stock Information
- Founded
- VTR 1983
- DXCM 1999
- Country
- VTR United States
- DXCM United States
- Employees
- VTR N/A
- DXCM N/A
- Industry
- VTR Real Estate Investment Trusts
- DXCM Medical/Dental Instruments
- Sector
- VTR Real Estate
- DXCM Health Care
- Exchange
- VTR Nasdaq
- DXCM Nasdaq
- Market Cap
- VTR 27.3B
- DXCM 28.0B
- IPO Year
- VTR 1998
- DXCM 2005
- Fundamental
- Price
- VTR $61.07
- DXCM $78.41
- Analyst Decision
- VTR Buy
- DXCM Buy
- Analyst Count
- VTR 10
- DXCM 17
- Target Price
- VTR $61.60
- DXCM $101.88
- AVG Volume (30 Days)
- VTR 2.4M
- DXCM 3.8M
- Earning Date
- VTR 10-30-2024
- DXCM 02-06-2025
- Dividend Yield
- VTR 2.95%
- DXCM N/A
- EPS Growth
- VTR N/A
- DXCM 83.21
- EPS
- VTR N/A
- DXCM 1.67
- Revenue
- VTR $4,797,115,000.00
- DXCM $3,954,000,000.00
- Revenue This Year
- VTR N/A
- DXCM $13.10
- Revenue Next Year
- VTR $7.07
- DXCM $14.79
- P/E Ratio
- VTR N/A
- DXCM $46.89
- Revenue Growth
- VTR 10.05
- DXCM 16.19
- 52 Week Low
- VTR $41.45
- DXCM $62.34
- 52 Week High
- VTR $67.61
- DXCM $142.00
- Technical
- Relative Strength Index (RSI)
- VTR 34.35
- DXCM 58.74
- Support Level
- VTR $61.73
- DXCM $77.33
- Resistance Level
- VTR $62.29
- DXCM $82.26
- Average True Range (ATR)
- VTR 1.00
- DXCM 2.36
- MACD
- VTR -0.30
- DXCM 0.07
- Stochastic Oscillator
- VTR 8.65
- DXCM 60.51
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.